GL1X · GenesisL1 explorer

Research workbench

Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design

Analyse Structures of glycogen phosphorylase-inhibitor complexes and the implications… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1FU7
Type
protein
Length
830 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen phosphorylase
EC
2.4.1.1
UniProt
P00489
Ligands
CR1, PLP
Pockets
14 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen phosphorylase (EC 2.4.1.1)protein83050% helix, 14% strandP00489

Ligands and binding sites

  • CR1 · N-(methoxycarbonyl)-beta-D-glucopyranosylamine · ligand · chains A
  • PLP · Pyridoxal-5'-phosphate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13090.850.9653CR1, PLP
21590.800.9643empty
32970.710.8531empty
41690.540.7924empty
51150.520.8119empty

Modifications

Observed in the structure: 1 cofactor (pyridoxal phosphate Schiff base).

Compared structures

  • 1FU7 · Structures of glycogen phosphorylase-inhibitor complexes and the implications for… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.